Doha, Qatar, 4th March 2025, ZEX PR WIRE, Net Summit Qatar units the stage for large bulletins, and this yr, Juleb, the main Observe & Hint compliance answer in Saudi Arabia, is making waves. Identified for its highly effective and modular ERP tailor-made for the pharmaceutical sector, Juleb has formally unveiled its US enlargement technique, aiming to assist corporations obtain full DSCSA (Drug Provide Chain Safety Act) compliance forward of looming deadlines—whereas avoiding expensive fines and operational dangers.

Juleb: Pioneering Observe & Hint Compliance within the GCC

Based with a mission to streamline and digitize the pharmaceutical provide chain, Juleb has turn into a market chief in Saudi Arabia for Observe & Hint compliance. Its AI-powered ERP platform gives end-to-end options designed to satisfy complicated regulatory necessities whereas bettering operational effectivity for producers, re-packagers, wholesalers and pharmacy retailers.

Juleb’s modular method permits companies to tailor the ERP to particular operational wants, whether or not it’s enhancing stock administration, simplifying B2B gross sales, or guaranteeing full regulatory compliance. The system seamlessly integrates with present ERPs and WMSs  provides real-time visibility throughout all the provide chain, making it the go-to answer for corporations seeking to optimize processes and cut back dangers.

Presently, Many ERP and track-and-trace options carried out within the US pharmaceutical sector face interoperability points, as nicely an enormous operational slowdown resulting from further required labor and reporting overhead. Juleb understands the frustration from these hurdles and solves each issues seamlessly. Juleb handles all of the aggregation file codecs from different software program suppliers, so corporations would achieve peace of thoughts from realizing that compliance is achieved with precision and ease. Whereas operationally, with the bolt-scanning and ERP integration, the roadblocks from handbook labor and reporting overheads are remodeling to considerably shorter and streamlined processes, embodying the promise of operational excellence.

Increasing into the US: Serving to Companies Navigate DSCSA Compliance

With the DSCSA deadlines quick approaching—Could 27, 2025, for producers and repackagers, August 27, 2025, for wholesalers, and November 27, 2025, for bigger dispensers—US-based Pharmaceutical corporations and accredited Drug  Distributors are racing to align their operations with the brand new laws.

Non-compliance comes with heavy penalties:

• Fines up to $500,000 for entities
• Particular person fines of up to $250,000
• Suspension of licenses, product confiscations, and additional civil penalties

Juleb’s enlargement into the US market goals to assist wholesalers, distributors, and producers navigate these challenges. With its Observe & Hint management in KSA and a confirmed observe report of serving to corporations obtain compliance, Juleb is completely positioned to assist US companies in adapting to the DSCSA framework.

“A Global Vision for a Stronger Pharma Supply Chain”

“Web Summit Qatar is the ideal platform to announce our US expansion,” mentioned Yousuf Jamjoom, CEO of Juleb. “Our mission has always been to empower the pharmaceutical supply chain through smart, scalable solutions. As DSCSA deadlines loom, we’re stepping in to ensure companies can focus on what matters—delivering quality medications—while we handle the complexities of compliance.”

Juleb’s US technique consists of:

• Concentrating on small-to-medium wholesalers for early DSCSA compliance
• Localized modules tailor-made for US regulatory necessities
• Devoted assist groups for onboarding and compliance audits
• AI-powered analytics for real-time compliance monitoring

What Makes Juleb Completely different?

• Observe & Hint Experience: #1 in KSA, now bringing its management to the US market
• Modular ERP: Serving manufacturing, wholesale and retail with scalable options
• Actual-Time Visibility: Superior BI dashboards to assist data-driven decision-making
• Quick Deployment: Serving to companies go from complicated processes to streamlined operations in weeks
• Price-Effectivity: Keep away from heavy fines and cut back operational inefficiencies

Wanting Forward: Juleb’s Larger Growth Plans

Whereas the US enlargement is a serious focus, Juleb has its sights set on broader international alternatives. With over 40 international locations implementing Observe & Hint laws, Juleb goals to turn into a international chief in pharmaceutical provide chain options, serving to corporations adjust to evolving regulatory frameworks whereas optimizing their operations.

The corporate can be investing in AI-powered instruments, enhancing warehouse mobility options, and creating B2B gross sales pressure mobility options, fostering a extra interconnected and environment friendly pharma provide chain to make sure their companions are future-ready and outfitted to excel.

For extra info, You may Go to our website- https://juleb.com/dscsa